Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Hazardous Drug Laboratory Analysis (Core Testing Services)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves providing specialized chemical and biological testing services for hazardous drug samples, ensuring all work complies with ISO/IEC 17025 standards, standard operating procedures, and Quality Assurance/Quality Control requirements set by the Defense Health Agency. The scope includes sample preparation, the use of appropriate instrumentation, and the generation of raw analytical data to support accurate and reliable laboratory analysis. This subcontract, titled "Hazardous Drug Laboratory Analysis (Core Testing Services)," is issued by the Department of Defense through the Defense Health Agency and identifies Aberdeen as the primary location for performance. Classified under NAICS code 541380, the contract emphasizes strict adherence to regulatory and procedural standards to maintain the integrity and safety of hazardous drug testing operations.

General Info

Provide ISO/IEC 17025-compliant hazardous drug testing services at Aberdeen for Defense Health Agency.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

541380 - Testing Laboratories and ServicesView NAICS

Place of Performance

Aberdeen, MD, USA

Set-Aside

NONE

Documents

This scope was carved out of HT942726QE008.

The full solicitation package (4 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Hazardous Drug Sample Analysis

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Perform chemical and biological analysis of hazardous drug samples in compliance with ISO/IEC 17025, SOPs, and DHA QA/QC standards, including sample prep, instrumentation, and raw data generation.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 339112
New
Federal
Draeger Perseus A500
Solicitation # HT940626QE112
The Defense Health Agency intends to award a firm-fixed-price, sole-source contract to Draeger Inc. for the procurement of seven Draeger Perseus A500 anesthesia workstations integrated with the Infinity Acute Care System (IACS). These units will serve as one-for-one replacements for end-of-life systems at Winn Army Community Hospital in Fort Stewart, Georgia, which have reached their ten-year service limit. The acquisition includes the necessary labor, travel for repairs and preventative maintenance, and parts to ensure optimized equipment uptime. Delivery is required within eight weeks of the order issuance. The sole-source justification is based on the need for clinical standardization, patient safety, and seamless integration with the Infinity M540 patient monitor and the Military Health System Genesis electronic health record. By utilizing the Draeger system, the government aims to avoid approximately 120,000 dollars in retraining costs and 45,000 dollars in redundant supply chain expenses. The procurement is categorized under NAICS code 339112 and is funded via the Defense Health Program. While the agency intends to negotiate with Draeger Inc., it is accepting capability statements from other authorized OEM dealers or distributors until September 13, 2026, to determine if a competitive procurement is warranted.
Surgical and Medical Instrument Manufacturing

POSTED

about 23 hours ago

DEADLINE

in 9 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS